A new study reveals that glucagon-like peptide-1 receptor agonists (GLP-1), which include weight loss and diabetes meds ...

Have you finally decided to explore treatment plans for weight loss or erectile dysfunction? Are you finding that ...

New research estimates that expanded access to Ozempic and similar drugs could lead to 42,000 deaths prevented annually.

New research shows that Ozempic and similar drugs reduce opioid overdoses by 40% and alcohol intoxication by 50% in people ...

A review of the medical records of thousands of adolescents treated for obesity found that kids who received the GLP-1 medications semaglutide or liraglutide were less likely to ...

GLP-1 receptor agonists and similar drugs may protect people with opioid or alcohol use disorder from opioid overdose and ...

Weight-loss drugs such as Ozempic, made by Denmark's Novo Nordisk, can reduce rates of opioid and alcohol abuse by up to 50%, according to a new study that supports expectations the drugs can offer ...

Blockbuster diabetes and weight loss drugs, known as GLP-1 treatments, could help reduced the rate of overdoses and ...

Early data suggests GLP-1 drugs, renowned for their ability to assist in weight loss, may have a powerful effect on treating ...

Research from earlier this week is the latest to suggest that semaglutide and other GLP-1 drugs can help treat people's ...

Revolutionary weight management and diabetes medications could prove to be the next frontier in addiction recovery treatment medications.

A new study suggests increasingly popular GLP-1 drugs could help cut opioid and alcohol abuse nearly in half. What doesn’t it ...